239 related articles for article (PubMed ID: 19267366)
1. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.
Zhao H; Peehl DM
Prostate; 2009 Jun; 69(9):991-1000. PubMed ID: 19267366
[TBL] [Abstract][Full Text] [Related]
2. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium.
Pruitt FL; He Y; Franco OE; Jiang M; Cates JM; Hayward SW
Prostate; 2013 Apr; 73(5):476-88. PubMed ID: 22996917
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium.
Wilkinson SE; Furic L; Buchanan G; Larsson O; Pedersen J; Frydenberg M; Risbridger GP; Taylor RA
Prostate; 2013 Dec; 73(16):1810-23. PubMed ID: 24105601
[TBL] [Abstract][Full Text] [Related]
7. CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.
True LD; Zhang H; Ye M; Huang CY; Nelson PS; von Haller PD; Tjoelker LW; Kim JS; Qian WJ; Smith RD; Ellis WJ; Liebeskind ES; Liu AY
Mod Pathol; 2010 Oct; 23(10):1346-56. PubMed ID: 20562849
[TBL] [Abstract][Full Text] [Related]
8. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.
Huynh PT; Beswick EJ; Coronado YA; Johnson P; O'Connell MR; Watts T; Singh P; Qiu S; Morris K; Powell DW; Pinchuk IV
Int J Cancer; 2016 Apr; 138(8):1971-81. PubMed ID: 26595254
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer.
Brennen WN; Chen S; Denmeade SR; Isaacs JT
Oncotarget; 2013 Jan; 4(1):106-17. PubMed ID: 23362217
[TBL] [Abstract][Full Text] [Related]
10. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
[TBL] [Abstract][Full Text] [Related]
15. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
Brennen WN; Kisteman LN; Isaacs JT
Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
[TBL] [Abstract][Full Text] [Related]
16. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
18. CD90- (Thy-1-) high selection enhances reprogramming capacity of murine adipose-derived mesenchymal stem cells.
Kawamoto K; Konno M; Nagano H; Nishikawa S; Tomimaru Y; Akita H; Hama N; Wada H; Kobayashi S; Eguchi H; Tanemura M; Ito T; Doki Y; Mori M; Ishii H
Dis Markers; 2013; 35(5):573-9. PubMed ID: 24282338
[TBL] [Abstract][Full Text] [Related]
19. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
20. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
